Holen Sie sich die Stockscreener-App
2.45
11.36%
0.25
Handel nachbörslich:
2.31
-0.14
-5.71%
Aethlon Medical Inc Aktie (AEMD) Neueste Nachrichten
AEMD Q1 2026 Earnings: Slightly Better Than Expected Loss Amid No RevenueTrending Entry Points - Newser
AEMD Q1 2026 Earnings: Narrower Slight Loss Surprise Supports Share RecoveryFiscal Year Earnings - Newser
AEMD Q1 2026 Earnings: Narrower-Than-Expected Loss Lifts SharesTrader Community Signals - Newser
Aethlon Medical (AEMD) Edges Higher, Testing Key Resistance at $2.26Trending Volume Leaders - Newser
Aethlon Medical (AEMD) Monitors Ebola Outbreak for Hemopurifier® Applications - GuruFocus
Aethlon Medical monitors Ebola outbreak in Congo, Uganda - Investing.com UK
Aethlon Medical monitors Ebola outbreak in Congo, Uganda By Investing.com - Investing.com South Africa
Experimental blood filter once used on Ebola patient readied for new outbreak - Stock Titan
AEMD Stock Price, Quote & Chart | AETHLON MEDICAL INC (NASDAQ:AEMD) - ChartMill
Aethlon Medical Q2 2026 Earnings Preview - MSN
Armistice Capital (AEMD) files Schedule 13G/A disclosing 4.99% stake - Stock Titan
TradingKey - TradingKey
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
What Aethlon (AEMD) is doing to earn customer loyalty (Risk Aversion) 2026-05-08Stock Entry Points - newser.com
AEMD (Aethlon) EPS beats estimates by narrow margin while shares fall 3.4% on zero revenue.Open Stock Signal Network - newser.com
Aethlon Medical signals expanded Australian oncology enrollment strategy while operating loss narrows to $1.5M - MSN
Aethlon Medical prices $4.5M public offering with 5-Year warrants; shares down 47% - MSN
CapEx per share of Aethlon Medical, Inc. – FWB:EJU1 - TradingView
AEMD (Aethlon Medical Inc.) posts narrow Q1 2026 EPS beat, shares tick higher on modest positive investor sentiment.Open Stock Picks - Xã Thanh Hà
Aethlon Medical (AEMD) director receives 21,815-share RSU award at $2.29 - Stock Titan
Director Chetan Shah receives 21,815 RSUs at Aethlon Medical (AEMD) - Stock Titan
Director at Aethlon Medical (AEMD) receives 21,815-share RSU grant - Stock Titan
Aethlon Medical (AEMD) director receives 21,815-share RSU stock grant - Stock Titan
Aethlon (AEMD) Stock Strangle (Smart Money Active) 2026-04-20Social Trade Signals - Xã Thanh Hà
Can Aethlon (AEMD) Stock Beat Estimates | Price at $2.16, Down 0.46%Real Trader Insights - Newser
Advancements in Novel Immunotherapeutics in The Oncology Battle - ADVFN
Fundamentals Check: Will Aethlon Medical Inc stock recover after earningsTrade Analysis Summary & High Yield Stock Recommendations - baoquankhu1.vn
US Market Wrap: Is Aethlon Medical Inc a strong growth stock2026 Historical Comparison & Expert Curated Trade Setups - baoquankhu1.vn
What is the fair value of Aethlon Medical Inc. stock now2026 Sector Review & Technical Pattern Based Signals - Bollywood Helpline
Is Aethlon (AEMD) Stock Undervalued Now | Price at $2.17, Up 2.36%Open Market Insights - Newser
Q3 2026 Aethlon Medical Inc Earnings Call Transcript - GuruFocus
Aethlon Medical Update: DSMB Clears Aussie Oncology Trial to Advance Hemopurifier to Cohort 3 - Defense World
Death Cross: How is Aethlon Medical Inc managing supply chain issues2026 Analyst Calls & Risk Controlled Daily Trade Plans - baoquankhu1.vn
Aethlon Medical (AEMD) director forfeits 178 shares to cover RSU taxes - Stock Titan
Aethlon Medical (NASDAQ: AEMD) director forfeits 178 shares for tax withholding - Stock Titan
Director at Aethlon (NASDAQ: AEMD) forfeits shares to cover taxes - Stock Titan
Aethlon Medical : Corporate OverviewMarch 2026 - marketscreener.com
Performance Recap: Whats the profit margin of Aethlon Medical IncQuarterly Profit Report & High Accuracy Investment Entry Signals - baoquankhu1.vn
Aethlon Medical advances to final cohort in cancer device trial By Investing.com - Investing.com Australia
Market Pulse: How is Aethlon Medical Inc managing supply chain issuesWeekly Trend Report & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review - Bitget
AEMD Technical Analysis & Stock Price Forecast - Intellectia AI
Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2026 earnings call transcript - MSN
Cancer device study moves forward after reviewers find no safety issues - Stock Titan
Novel Immunotherapeutics Stocks in the News (Nasdaq:AEMD), (Nasdaq:HURA) (NYSE: AZN) (Nasdaq: ELTX) - Investorideas.com
AEMD Trial Progress: Aethlon Medical Advances to Final Cohort - GuruFocus
Medical Tech Stock Aethlon Medical, Inc. (NASDAQ: AEMD) Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review - Investorideas.com
Aethlon Medical advances to final cohort in cancer device trial - Investing.com
Aug Closing: Does Aethlon Medical Inc offer margin of safetyWatch List & Fast Moving Stock Watchlists - baoquankhu1.vn
If You Invested $1,000 in Aethlon Medical (AEMD) - Stock Titan
Aethlon Medical, Inc.: Fundamental Analysis and Financial Ratings | EJU0 | US00808Y5050 - marketscreener.com
1.27%
2.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):